|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
University of New Mexico |
|---|---|
| Information provided by: | University of New Mexico |
| ClinicalTrials.gov Identifier: | NCT00322855 |
Purpose
To review the outcome of patients with soft tissue sarcoma treated with chemotherapy form 2004 and 2005.
| Condition |
|---|
|
Sarcoma |
| Study Type: | Observational |
| Study Design: | Cohort, Retrospective |
| Official Title: | Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma |
| Estimated Enrollment: | 20 |
| Study Start Date: | August 2005 |
| Estimated Study Completion Date: | August 2010 |
| Estimated Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Chart Review
patients diagnosed with soft tissue sarcoma
|
Chart review of patients with soft tissue sarcoma treated with chemotherapy form 2004 and 2005 to determine outcome
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Patients with soft tissue sarcoma treated with chemotherapy form 2004 and 2005.
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, New Mexico | |
| University of New Mexico | |
| Albuquerque, New Mexico, United States, 87131 | |
| Principal Investigator: | Aroop Mangalik, MD | University of New Mexico |
More Information
| Responsible Party: | University of New Mexico ( Aroop Manglik, MD; Principal Investigator ) |
| Study ID Numbers: | INST 0517C |
| Study First Received: | May 5, 2006 |
| Last Updated: | October 1, 2008 |
| ClinicalTrials.gov Identifier: | NCT00322855 |
| Health Authority: | United States: Institutional Review Board |
|
Neoplasms, Connective and Soft Tissue Malignant mesenchymal tumor Sarcoma Soft tissue sarcomas |
|
Neoplasms Neoplasms by Histologic Type |
